Recombinant Adenine deaminase (WS0737)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs unless dry ice shipping is requested in advance. Additional charges apply for dry ice shipping.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, which can serve as a guideline.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
WS0737Adenine deaminase; ADE; EC 3.5.4.2; Adenine aminohydrolase; AAH
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-331
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Wolinella succinogenes (strain ATCC 29543 / DSM 1740 / LMG 7466 / NCTC 11488 / FDC 602W) (Vibrio succinogenes)
Target Names
WS0737
Target Protein Sequence
MPTLKELIAK LPKAELHLHI EGSLEPELMF ELAQKNRIPL PYKSVEEVRK AYSFTSLQSF LDIYYAGAKV LLTESDFFDL AWAYLLRCKA QNICHTEIFF DPQTHTSRGV SFETVIEGIT KALEKGEKEL GISSFLIMCF LRHLSESEGF EILKSSLPFR EKILGVGLDS SEVGHPPSKF ERLFLECRKA GYKIVAHAGE EGDSSYIWEA IHKLQVERID HGIRCEEDEN LVEWLIQKQT PLTVCPLSNV KLQAVKNLSE HNILRLLRKG VLVTVNSDDP AYFGGYLNEN YEALSEHLNA SKEELKALAI NSFKASFLSE EKKMDWIKQI I
Uniprot No.

Target Background

Function

Adenine deaminase catalyzes the hydrolytic deamination of adenine to hypoxanthine. It plays a crucial role in purine salvage pathways and nitrogen catabolism.

Database Links

KEGG: wsu:WS0737

STRING: 273121.WS0737

Protein Families
Metallo-dependent hydrolases superfamily, Adenosine and AMP deaminases family, Adenine deaminase type 2 subfamily

Q&A

What biochemical reaction does adenine deaminase catalyze and what is its role in purine metabolism?

Adenine deaminase (EC 3.5.4.2) catalyzes the hydrolytic deamination of adenine to produce hypoxanthine and ammonia. The reaction can be represented as:

Adenine + H₂O → Hypoxanthine + NH₃

This reaction represents an important step in purine metabolism, particularly in the purine salvage pathway. While most organisms can synthesize purines de novo, the salvage pathway allows cells to recycle free purine bases, which is energetically more efficient. By converting adenine to hypoxanthine, adenine deaminase creates a substrate that can be further metabolized to inosine monophosphate (IMP), a central intermediate in purine metabolism.

The enzyme requires a metal cofactor (typically zinc) for its catalytic activity. This cofactor activates a water molecule for nucleophilic attack on the C6 position of adenine, leading to the replacement of the amino group with a hydroxyl group.

What are the optimal storage conditions for maintaining recombinant adenine deaminase activity?

According to the product specification sheet, proper storage is critical for maintaining the enzymatic activity of recombinant adenine deaminase (WS0737). The recommended storage conditions are:

  • For liquid formulations: -20°C to -80°C with a typical shelf life of 6 months

  • For lyophilized formulations: -20°C to -80°C with a typical shelf life of 12 months

Additional storage recommendations include:

  • Avoiding repeated freeze-thaw cycles which can significantly reduce enzyme activity

  • Working aliquots can be stored at 4°C for up to one week

  • For reconstitution of lyophilized protein, briefly centrifuge the vial before opening to bring contents to the bottom

  • Reconstitute in deionized sterile water to a concentration of 0.1-1.0 mg/mL

  • Addition of glycerol (5-50% final concentration) is recommended for aliquoting and long-term storage, with 50% being the default recommendation

The shelf life depends on multiple factors including buffer components, storage temperature, and the intrinsic stability of the protein itself. Researchers should validate activity after long-term storage before using in critical experiments.

What are the typical kinetic parameters for adenine deaminase and how do they compare to other deaminases?

While specific kinetic parameters for WS0737 adenine deaminase are not provided in the available documentation, typical adenine deaminases exhibit the following kinetic characteristics:

ParameterTypical RangeNotes
Km for adenine5-50 μMReflects moderate to high affinity for substrate
kcat10-100 s⁻¹Moderate turnover rate
kcat/Km10⁵-10⁶ M⁻¹s⁻¹Good catalytic efficiency
pH optimum7.0-8.0Slightly alkaline preference
Temperature optimum30-40°CConsistent with mesophilic origin

Compared to adenosine deaminase (which acts on nucleosides rather than free bases), adenine deaminase typically shows:

  • Higher Km values (lower affinity) for its substrate

  • Different substrate specificity profiles

  • Distinct structural features in the substrate binding pocket

These parameters must be experimentally determined for each specific enzyme preparation to account for species differences, expression systems, and purification methods.

How does adenine deaminase activity compare to ADP/ATP exchange activity in recombinant protein systems?

Adenine deaminase and ADP/ATP exchange proteins (such as adenine nucleotide translocase, ANT) represent different classes of enzymes with distinct activities, though both involve adenine-containing molecules.

Research on recombinant ANT1 showed ADP/ATP exchange rates of approximately 3.49 ± 0.41 mmol/min/g protein when measured using a fluorescence-based assay with Magnesium Green (MgGr™) . This method exploits the different binding affinities of Mg²⁺ for ATP versus ADP.

In contrast, adenine deaminase activity:

  • Acts on free adenine rather than nucleotides

  • Does not involve exchange reactions but rather irreversible deamination

  • Can be measured by following the conversion of adenine to hypoxanthine spectrophotometrically

  • Typically exhibits specific activities in the range of 10-200 μmol/min/mg protein, depending on the source and preparation

The different methodological approaches reflect the distinct biochemical mechanisms of these enzymes. While fluorescence-based methods are effective for monitoring nucleotide exchange, adenine deaminase activity is typically measured by:

  • Direct spectrophotometric monitoring of the absorbance change as adenine converts to hypoxanthine

  • HPLC analysis of substrate consumption and product formation

  • Coupling reactions that detect the released ammonia

What methodological approaches are available for measuring adenine deaminase activity in vitro?

Several robust methodological approaches are available for measuring adenine deaminase activity in vitro:

  • Spectrophotometric assays:

    • Direct monitoring of the absorbance change at 265 nm (ΔƐ = -8600 M⁻¹cm⁻¹) as adenine converts to hypoxanthine

    • Advantages: continuous, real-time monitoring; simple equipment requirements

    • Limitations: interference from other UV-absorbing components; limited sensitivity

  • HPLC-based methods:

    • Separation and quantification of adenine and hypoxanthine

    • Advantages: high specificity; can detect multiple reaction components

    • Limitations: discontinuous sampling; requires specialized equipment

  • Ammonia detection:

    • Detection of released NH₃ using coupled enzyme assays (e.g., glutamate dehydrogenase)

    • Advantages: can be adapted to colorimetric or fluorometric formats

    • Limitations: indirect measurement; potential interference from other ammonia sources

  • Coupled enzyme assays:

    • Link hypoxanthine formation to another enzymatic reaction (e.g., xanthine oxidase)

    • Similar to how ANT activity can be measured using the MgGr™ fluorescence-based assay

    • Advantages: potentially higher sensitivity; continuous monitoring

    • Limitations: dependence on coupling enzyme performance

  • Radiochemical assays:

    • Using radiolabeled adenine and measuring conversion to hypoxanthine

    • Advantages: high sensitivity; directly measure substrate conversion

    • Limitations: handling radioactive materials; discontinuous sampling

The choice of method depends on the specific research question, available equipment, sensitivity requirements, and the complexity of the sample matrix being analyzed.

What are the recommended protocols for reconstituting lyophilized recombinant adenine deaminase?

The product documentation provides specific guidelines for reconstituting lyophilized recombinant adenine deaminase (WS0737) :

  • Initial preparation:

    • Briefly centrifuge the vial prior to opening to bring the contents to the bottom

    • This prevents loss of material and improves reconstitution efficiency

  • Reconstitution procedure:

    • Add deionized sterile water to achieve a final concentration of 0.1-1.0 mg/mL

    • Gently mix by inversion or slow swirling to avoid foam formation

    • Allow complete dissolution before proceeding

  • Stability enhancement:

    • Add glycerol to a final concentration of 5-50% (the default recommendation is 50%)

    • This stabilizes the protein and prevents freeze-thaw damage

    • Mix thoroughly to ensure homogeneous distribution

  • Storage preparation:

    • Aliquot the reconstituted protein into small volumes to minimize freeze-thaw cycles

    • Store at -20°C or -80°C for long-term preservation

    • Label aliquots with concentration, date, and batch information

  • Short-term storage:

    • Working aliquots can be stored at 4°C for up to one week

    • Avoid repeated freezing and thawing as this significantly reduces enzyme activity

For optimal results, researchers should verify enzyme activity after reconstitution before proceeding with critical experiments. The specific activity should be determined under standardized conditions to ensure batch-to-batch consistency.

How should researchers optimize buffer conditions for adenine deaminase activity assays?

Optimizing buffer conditions is critical for achieving maximum adenine deaminase activity. A systematic approach should include:

  • Buffer selection and pH optimization:

    • Test multiple buffers with overlapping pH ranges:

      • MES (pH 5.5-6.5), Phosphate (pH 6.0-8.0), Tris (pH 7.5-9.0)

    • Typical optimal pH range is 7.0-8.0 for most adenine deaminases

    • Use consistent buffer concentration (typically 50-100 mM)

    • Avoid buffers that might chelate metal ions or inhibit the enzyme

  • Metal cofactor optimization:

    • As an amidohydrolase, adenine deaminase typically requires metal cofactors

    • Test various divalent cations (Zn²⁺, Mg²⁺, Mn²⁺) at 0.1-1.0 mM

    • Include EDTA controls to confirm metal dependency

    • The sequence motif "GYKIVAHAGE" in WS0737 suggests a metal-binding site

  • Ionic strength adjustment:

    • Test NaCl concentrations from 0-500 mM

    • Some enzymes show enhanced stability at moderate ionic strength

    • High salt can affect substrate binding and catalytic efficiency

  • Stabilizing additives:

    • Consider adding BSA (0.1-1.0 mg/mL) to prevent surface denaturation

    • Test reducing agents (DTT, β-mercaptoethanol at 1-5 mM) if the enzyme contains critical cysteine residues

    • Glycerol (5-10%) can enhance stability without significantly affecting activity

  • Systematic optimization matrix:

    • Use a matrix approach testing different combinations of the above factors

    • Measure activity under each condition and identify optimal combinations

    • Verify results with multiple enzyme concentrations and substrate levels

By systematically optimizing these parameters, researchers can establish robust assay conditions that maximize enzyme activity while maintaining stability.

What control experiments are essential when studying adenine deaminase activity?

Robust control experiments are crucial for reliable adenine deaminase activity studies. Essential controls include:

  • Enzyme specificity controls:

    • No-enzyme controls: Complete reaction mixture without enzyme to check for non-enzymatic adenine deamination

    • Heat-inactivated enzyme controls: Enzyme sample pre-treated at 95°C for 10 minutes to confirm that observed activity is due to the active protein

    • Substrate specificity controls: Test activity with related compounds (adenosine, other purines) to verify enzyme specificity

  • Assay validation controls:

    • Linear range determination: Verify that measurements are made in the linear range of both enzyme concentration and reaction time

    • pH controls: Ensure buffer capacity is sufficient to maintain constant pH throughout the reaction

    • Temperature controls: Maintain constant temperature during reactions to prevent activity fluctuations

  • Mechanism validation controls:

    • Metal dependence: Test activity with and without added metal ions, and with chelating agents (EDTA)

    • Product inhibition: Add hypoxanthine to reaction mixtures to assess potential feedback inhibition

    • Known inhibitors: Include established inhibitors as positive controls for inhibition studies

  • Data quality controls:

    • Technical replicates: Multiple measurements of the same sample to assess method precision

    • Biological replicates: Independent preparations to assess reproducibility

    • Standard curves: For all quantitative measurements to ensure linearity of detection

This approach, similar to validation methods used in studies of ADP/ATP exchange proteins , ensures that observed enzyme activity is specifically attributable to adenine deaminase and not to artifacts or contaminating activities.

How can researchers determine enzyme kinetic parameters for recombinant adenine deaminase?

Determination of kinetic parameters for recombinant adenine deaminase requires a systematic approach similar to that used for other enzymes:

  • Experimental setup:

    • Prepare adenine solutions ranging from approximately 0.2 × Km to 5 × Km

    • If Km is unknown, use a broad range (e.g., 1-1000 μM)

    • Use optimized buffer conditions determined in preliminary experiments

    • Maintain constant temperature (typically 25°C or 37°C)

    • Use enzyme concentration that gives linear activity for at least 5-10 minutes

  • Data collection:

    • Measure initial reaction rates at each substrate concentration

    • Ensure measurements are made in the linear portion of the progress curve (typically <10% substrate conversion)

    • Include sufficient replicates (minimum triplicate) for statistical validity

  • Data analysis:

    • Plot initial velocity (v₀) versus substrate concentration [S]

    • Fit data to the Michaelis-Menten equation: v₀ = Vmax × [S] / (Km + [S])

    • Use non-linear regression software (GraphPad Prism, SigmaPlot, etc.)

    • Calculate key parameters:

      • Km: Substrate concentration at half-maximal velocity

      • Vmax: Maximal velocity at saturating substrate

      • kcat: Turnover number (Vmax/[E]total)

      • kcat/Km: Catalytic efficiency

  • Alternative analysis approaches:

    • For non-Michaelis-Menten kinetics, test alternative models:

      • Substrate inhibition: v = Vmax × [S] / (Km + [S] + [S]²/Ki)

      • Cooperative binding: v = Vmax × [S]ⁿ / (K₀.₅ⁿ + [S]ⁿ)

    • Compare models using statistical criteria (Akaike Information Criterion, F-test)

This approach is similar to methods used for characterizing recombinant proteins like ANT1, where proper kinetic analysis is essential for understanding enzyme function .

What are common sources of error in adenine deaminase activity measurements and how can they be minimized?

Several common sources of error can affect adenine deaminase activity measurements. Recognizing and minimizing these errors is crucial for obtaining reliable data:

  • Enzyme stability issues:

    • Error: Activity loss during storage or experiment can produce inconsistent results

    • Solution: Store enzyme according to recommendations (glycerol addition, proper temperature) ; prepare fresh dilutions for each experiment; include stability controls

  • Substrate-related problems:

    • Error: Impure adenine or degradation during storage can affect measurements

    • Solution: Use highest purity reagents; prepare fresh solutions; protect from light; verify substrate purity occasionally by HPLC

  • Buffer composition effects:

    • Error: Some buffer components may interfere with enzyme activity or detection methods

    • Solution: Systematically test buffer components; be consistent with buffer preparation; check pH before and after reactions

  • Detection method limitations:

    • Error: Non-linearity in spectrophotometric assays at high absorbance; background interference

    • Solution: Validate assay linearity; use appropriate blanks; dilute samples if necessary

  • Improper enzyme concentration:

    • Error: Too high enzyme concentration leads to rapid substrate depletion; too low gives poor signal

    • Solution: Optimize enzyme concentration to achieve linear rates for at least 5-10 minutes

  • Temperature fluctuations:

    • Error: Activity varies significantly with temperature

    • Solution: Use temperature-controlled instruments; pre-equilibrate all components

  • Metal ion availability:

    • Error: Insufficient or inhibitory levels of metal cofactors

    • Solution: Optimize metal ion concentration; avoid metal chelators in buffers

  • Batch-to-batch variation:

    • Error: Different preparations show variable specific activity

    • Solution: Determine specific activity for each batch; normalize results; include reference standards

These approaches align with best practices in enzyme assay development, as demonstrated in studies of other recombinant enzymes like those measuring ADP/ATP exchange .

How can recombinant adenine deaminase be used in nucleotide metabolism studies?

Recombinant adenine deaminase serves as a valuable tool in nucleotide metabolism studies through several research applications:

  • Purine salvage pathway investigation:

    • Map flux through the adenine deamination step

    • Compare activity across different cell types or physiological states

    • Combine with other purine metabolism enzymes to reconstitute pathway segments in vitro

  • Metabolic flux analysis:

    • Use recombinant adenine deaminase in concert with isotope-labeled adenine

    • Track metabolic fate of purine bases through various pathways

    • Quantify the relative contribution of de novo synthesis versus salvage pathways

  • Enzyme kinetic methodology development:

    • Similar to the fluorescence-based methods developed for studying ADP/ATP exchange

    • Develop coupled assay systems linking adenine deamination to detectable signals

    • Create high-throughput screening platforms for inhibitor discovery

  • Comparative biochemistry:

    • Study species differences in adenine deaminase properties

    • Investigate evolutionary relationships among purine-metabolizing enzymes

    • Compare catalytic mechanisms across the amidohydrolase superfamily

  • Analytical applications:

    • Use as a reagent in adenine quantification assays

    • Employ in biosensor development for adenine detection

    • Apply in sample preparation to remove adenine in nucleotide mixtures

By incorporating recombinant adenine deaminase into these research approaches, investigators can gain deeper insights into nucleotide metabolism under various physiological and pathological conditions.

What approaches are recommended for studying inhibitors of adenine deaminase?

Studying inhibitors of adenine deaminase requires a systematic approach that balances throughput with mechanistic detail:

  • Initial inhibitor screening:

    • Use a fixed concentration of adenine (at or near Km)

    • Test compounds at a single high concentration (50-100 μM)

    • Calculate percent inhibition relative to uninhibited controls

    • Identify hit compounds for detailed characterization

  • IC₅₀ determination:

    • Test 7-10 inhibitor concentrations in 2-3 fold dilution series

    • Include appropriate controls (no enzyme, no inhibitor)

    • Plot percent activity versus log[inhibitor]

    • Fit data to sigmoidal dose-response equation

  • Inhibition mechanism studies:

    • Perform kinetic assays at 3-5 substrate concentrations

    • Use 3-4 fixed inhibitor concentrations

    • Create Lineweaver-Burk plots (1/v versus 1/[S])

    • Determine inhibition type based on line intersection patterns:

      • Competitive: lines intersect on y-axis

      • Noncompetitive: lines intersect on x-axis

      • Uncompetitive: parallel lines

      • Mixed: lines intersect elsewhere

  • Structure-activity relationship analysis:

    • Test series of related compounds with systematic structural variations

    • Correlate structural features with inhibitory potency

    • Use computational modeling to predict binding modes

  • Reversibility assessment:

    • Pre-incubate enzyme with inhibitor, then dilute or dialyze

    • Measure recovery of enzyme activity

    • Distinguish between reversible and irreversible inhibitors

This methodological framework is similar to approaches used in studying inhibitors of other enzymes, including the use of specific inhibitors like carboxyatractyloside and bongkrekic acid in ANT1 studies .

How can researchers address unexpected low activity of recombinant adenine deaminase?

Unexpected low activity of recombinant adenine deaminase can stem from multiple causes. A systematic troubleshooting approach includes:

  • Enzyme preparation issues:

    • Verify reconstitution protocol was followed correctly

    • Check pH of reconstitution buffer (should be neutral to slightly alkaline)

    • Ensure protein was not over-concentrated during reconstitution

    • Verify proper storage conditions were maintained

  • Assay condition optimization:

    • Confirm optimal buffer composition and pH (typically 7.0-8.0)

    • Test different metal cofactors (Zn²⁺, Mg²⁺, Mn²⁺) at various concentrations

    • Examine effect of ionic strength on activity

    • Verify substrate quality and concentration

  • Enzyme quality assessment:

    • Run SDS-PAGE to verify protein integrity

    • Check for precipitation or aggregation

    • Measure protein concentration using multiple methods

    • Consider active site titration with tight-binding inhibitors

  • Detection method verification:

    • Run positive controls with known active enzyme preparations

    • Verify detection system with standard curves

    • Check for interfering components in the reaction mixture

    • Consider alternative detection methods

  • Batch characterization:

    • Compare with reference batches or standards

    • Document specific activity under standardized conditions

    • Test activity after various storage periods to assess stability

    • Consider protein refolding protocols if misfolding is suspected

This troubleshooting approach parallels methods used in studies of other recombinant enzymes, where careful optimization of assay conditions is essential for reliable activity measurements .

What strategies can be used to minimize batch-to-batch variation in recombinant adenine deaminase studies?

Minimizing batch-to-batch variation is crucial for obtaining reproducible results in adenine deaminase studies. Effective strategies include:

  • Standardized production protocols:

    • Maintain consistent expression system and conditions

    • Document all production parameters (induction time, temperature, etc.)

    • Use the same purification protocol and buffers

    • Implement quality control checkpoints throughout the process

  • Comprehensive batch characterization:

    • Determine specific activity under standardized conditions

    • Assess protein purity by multiple methods (SDS-PAGE, chromatography)

    • Verify protein concentration using multiple techniques

    • Measure kinetic parameters (Km, Vmax) for each batch

  • Reference standards and normalization:

    • Maintain a well-characterized reference batch

    • Express activities relative to the reference standard

    • Calculate normalization factors based on specific activity ratios

    • Include the reference standard in key experiments

  • Experimental design considerations:

    • Complete comparative experiments with the same batch when possible

    • If using multiple batches, distribute them evenly across experimental conditions

    • Include batch as a variable in statistical analyses

    • Use randomized block designs with batch as a blocking factor

  • Statistical approaches:

    • Apply mixed-effects models that account for batch as a random effect

    • Use ANCOVA with batch as a covariate

    • Calculate and report confidence intervals that account for batch variation

  • Storage optimization:

    • Follow recommended storage conditions precisely (temperature, additives)

    • Add stabilizers as recommended (50% glycerol for long-term storage)

    • Create uniform aliquots to minimize freeze-thaw cycles

    • Monitor activity over time to establish stability profiles

These approaches align with best practices in enzyme research and are similar to methods used to ensure reproducibility in studies of other recombinant proteins .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.